SCA practice case · Video consultation
“I started a new tablet, now I’ve got a spreading rash, blisters and my mouth and eyes are raw”
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Nadia Karim · 34 years · female
Setting
Video/urgent — severe rash after a new drug (observations cannot be taken on video).
Past history
- Epilepsy; lamotrigine started about ten days ago
Medication
- Lamotrigine (started about ten days ago; suspected culprit)
Allergies
None recorded before this
Recent notes
⚠ Spreading painful blistering rash, skin peeling, mouth, eye and genital soreness, fever.
Reason for contact
Urgent video: “Is this the tablet?”
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
STEVENS-JOHNSON SYNDROME / TOXIC EPIDERMAL NECROLYSIS (SJS/TEN) is a life-threatening severe cutaneous adverse drug reaction: a recent culprit DRUG plus a PAINFUL (not merely itchy) rash with dusky/target macules, BLISTERS and skin detachment (Nikolsky+), and crucially MUCOSAL erosions of ≥2 of mouth/eyes/genitals, with fever and systemic illness (SJS <10% body-surface detachment, SJS/TEN overlap 10–30%, TEN >30% — BAD UK guidelines 2016). The combination of mucosal involvement, skin detachment and a culprit drug is the alarm. Identify the culprit (antiepileptics — lamotrigine/carbamazepine/phenytoin; allopurinol; sulfonamide/other antibiotics; oxicam NSAIDs; nevirapine), typically started days-weeks before, and STOP it immediately (for an antiepileptic the hospital arranges safe seizure cover), documenting a severe drug allergy and reporting on a Yellow Card (MHRA), since re-exposure can be fatal and prompt withdrawal improves outcome. Recognise an EMERGENCY with significant mortality (skin failure causes fluid/electrolyte loss, thermoregulation failure, infection/sepsis, eye/mucosal complications) and arrange IMMEDIATE admission — dermatology with burns/ITU-level supportive care and EARLY ophthalmology, with a sepsis risk assessment (NICE NG253; observations cannot be taken on video) — not community management. Know the differential: erythema multiforme (milder, target lesions, often post-HSV, less mucosal/systemic), staphylococcal scalded skin (mostly young children, no mucosa), and DRESS (rash, fever, eosinophilia, organ involvement). Communicate the urgency clearly but calmly, arrange emergency transfer, and ensure the drug is stopped and documented. The skill is rapid pattern recognition, stopping the drug, and emergency admission — not a community antihistamine.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.